about
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThree drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in UgandaNifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case seriesNECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sicknessMalaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004Monitoring the elimination of human African trypanosomiasis: Update to 2014The unknown risk of vertical transmission in sleeping sickness--a literature review.Needs assessment for performance improvement of personnel in charge of epidemiological surveillance in Morocco.Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis.Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasisSafety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis.Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and riskPrevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan.Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial.Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda.The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school.Congenital Trypanosomiasis in Child Born in France to African Mother.Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.Tackling imported tropical diseases in China.
P50
Q28250035-4CD6AB78-2136-4BB0-897C-EB4875D9B6F0Q28469079-2310E32D-C7EF-4348-BE78-5628AA3FD1D5Q28471706-10396B3E-EF92-4782-951C-0D16558E8488Q28474074-CA391DD7-070D-4AB6-9650-AA2D4E39B4C1Q28731618-90C18A9C-9F2D-4A34-B762-E3F0EF412E4EQ33758003-89843737-58A5-4955-879A-74D5067508D4Q33784136-190A148F-E959-4693-A513-F5FA968C0EEEQ33856085-D6B20380-D21E-4688-B7DD-583F5D73BB41Q33959416-982ACDAE-06FA-47FF-A3C3-03328883B327Q34305891-3331DFC9-3B81-4866-92E2-EC44F8AB63F3Q34589130-26AA7ABC-AD2C-4CAC-82E6-87AFF82A09CCQ35657780-61034A19-AC44-4DAD-8939-66062318EDE7Q35848347-EADBD876-E4E9-4F0C-AC83-261FF7ED71B8Q36198356-19B8E5F4-00E8-4CD8-9D86-6FF347A0E7F4Q38875419-A97D9A07-524F-4A1E-AD08-013C0323A057Q38878510-D9F64FFA-E671-45AF-BDA5-DB81B2D9D255Q38881940-A31A5F95-C684-41EF-85A7-3D18FC0BEE62Q38882218-CFFF34CC-20A5-4173-B263-B2F9F991E842Q38884439-CB06599A-D7C3-4E60-ADF1-B1A429D63D1BQ42804550-B1464338-3B06-476E-B75F-4C5EA899B112Q46309751-810C79FE-E307-45FF-BA22-648E68D01B25Q50148571-EF0C9D8C-466B-4DDA-B50C-0B5C73883EA5
P50
name
Gerardo Priotto
@ast
Gerardo Priotto
@en
Gerardo Priotto
@es
Gerardo Priotto
@nl
type
label
Gerardo Priotto
@ast
Gerardo Priotto
@en
Gerardo Priotto
@es
Gerardo Priotto
@nl
prefLabel
Gerardo Priotto
@ast
Gerardo Priotto
@en
Gerardo Priotto
@es
Gerardo Priotto
@nl